This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB08318/identifier/pdb/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08318/identifier/pubchem-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08318/identifier/pubchem-substance/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08318/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08318
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB08318 n11:DB08318
dcterms:title
6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine
adms:identifier
n7:DB08318 n8:OA5 n12:25271557 n13:99444789
n3:IUPAC-Name
n4:271B4C6F-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4C75-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4C74-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4C71-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4C72-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4C73-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4C6D-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4C6B-363D-11E5-9242-09173F13E4C5 n4:271B4C6E-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4C6C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4C7B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4C7C-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4C76-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4C77-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4C79-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4C78-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4C7A-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4C81-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4C83-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4C84-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4C80-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4C7F-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4C82-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4C70-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4C7D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4C7E-363D-11E5-9242-09173F13E4C5